Verkkoin this article, we highlight six areas of innovation that have the potential to reduce the burden of diabetes for individuals living with the condition.
Verkkostimuli responsive materials for the controlled delivery of insulin or glucagon are a promising alternative to glucose monitors and insulin pumps.
Verkkothe us food and drug administration (fda) recently approved donislecel, marketed by celltrans inc as lantidra, for the treatment of type 1 diabetes in adults who.